Chicago, IL, United States of America

Dennis Andress

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Dennis Andress in Cardiovascular Health

Introduction

Dennis Andress is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of cardiovascular health through his innovative research and patenting efforts. His work focuses on methods to improve lipid profiles, which are crucial for reducing cardiovascular risk.

Latest Patents

Dennis Andress holds a patent titled "Methods for improving lipid profiles using atrasentan." This patent outlines methods for reducing cardiovascular risk in human subjects by administering atrasentan, or a pharmaceutically acceptable salt thereof. The methods aim to achieve a reduction of about 5% or more in total serum cholesterol and serum LDL cholesterol compared to the subject's baseline levels.

Career Highlights

Dennis Andress is currently associated with AbbVie Inc., a leading biopharmaceutical company. His work at AbbVie has allowed him to focus on innovative solutions that address critical health issues, particularly in cardiovascular disease management.

Collaborations

Throughout his career, Dennis has collaborated with notable colleagues, including Blas Coll Crespo and John J Brennan. These collaborations have fostered a productive environment for innovation and research in the field of pharmaceuticals.

Conclusion

Dennis Andress exemplifies the spirit of innovation in the healthcare sector, particularly through his patent on improving lipid profiles. His contributions continue to impact cardiovascular health positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…